EP Patent

EP0467389B1 — Drug delivery system comprising interaction between calcitonin and a hydrophobic biodegradable polymer

Assigned to University of Kentucky Research Foundation · Expires 1999-10-06 · 27y expired

What this patent protects

A drug delivery system for controlled release of a protein or polypeptide comprising a hydrophobic biodegradable polymer and a protein or polypeptide. A physical interaction is present between the polymer and the protein or polypeptide, thus, allowing protection and controlled re…

USPTO Abstract

A drug delivery system for controlled release of a protein or polypeptide comprising a hydrophobic biodegradable polymer and a protein or polypeptide. A physical interaction is present between the polymer and the protein or polypeptide, thus, allowing protection and controlled release of the protein or polypeptide in-vivo. The drug delivery system may be prepared by a polymer precipitation technique or a microsphere technique.

Drugs covered by this patent

Patent Metadata

Patent number
EP0467389B1
Jurisdiction
EP
Classification
Expires
1999-10-06
Drug substance claim
No
Drug product claim
No
Assignee
University of Kentucky Research Foundation
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.